Likewise, in another prospective observational cohort study including 79 IBD patients (32 CD and 47 UC patients), concomitant TNF antagonists were not associated with SARS-CoV-2-related pneumonia or death [79]. This evidence concerns the gene TNF and susceptibility to pneumonia measurement.